59
Views
1
CrossRef citations to date
0
Altmetric
Review

Management of transient ischemic attack: 2005

, &
Pages 591-599 | Published online: 10 Jan 2014

References

  • Caplan LR. TIAs: we need to return to the question, ‘What is wrong with Mr. Jones?’ Neurology 38(5) 791–793 (1988).
  • Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency-department diagnosis of TIA. JAMA 284, 2901–2906 (2000).
  • Albers GW, Caplan LR, Easton JD et al. Transient ischemic attack – proposal for a new definition. N. Engl. J. Med. 347, 1713–1716 (2002).
  • Fleming KD, Brown RD, Petty GW et al. Evaluation and management of transient ischemic attack and minor cerebral infarction. Mayo Clin. Proc. 79(8), 1071–1086 (2004).
  • Easton DJ. Redefining TIA. Neurology 62(8, Suppl. 6), S1–S2 (2004).
  • Ovbiagele B, Kidwell CS, Saver JL. Epidemiological impact of a tissue-based definition of transient ischemic attack. Stroke 34, 919–924 (2003).
  • Latchaw RE, Yonas H, Hunter G et al. Guidelines and recommendations for perfusion imaging in cerebral ischaemia. Stroke 34, 1084–1104 (2003)
  • Donnan GA, Davis SM. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 h. Stroke 36, 1098–1099 (2005).
  • Weisberg LA. Clinical characteristics of transient ischemic attacks in black patients. Neurology 41, 1410–1414 (1991).
  • Levy DE. How transient are transient ischemic attacks? Neurology 38, 647–647 (1988).
  • Marler JR, Tilley BC, Lu M et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55, 1649–1655 (2000).
  • Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischemic attack or minor stroke. BMJ 328, 326 (2004).
  • Lovett JK, Dennis MS, Sandercock DM et al. Very early risk of stroke after a first transient ischemic attack. Stroke 34, E138–E142 (2003).
  • Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJM. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 170, 1105–1109 (2004).
  • Johnston SC, Easton JD. Are patients with acutely recoverable cerebral ischaemia more unstable? Stroke 34, 2446–2452 (2003).
  • North American SymptomaticCarotid Endarterectomy Trial Collaborators. Beneficial effects of carotid endarterctomy in symptomatic patients with high-grade stenosis. N. Engl. J. Med. 325, 445–453 (1991).
  • Benavente O, Eliasziw M, Streifler JY et al. Prognosis after transient monocular blindness with carotid artery stenosis. N. Engl. J. Med. 345, 1084–1090 (2001).
  • Evans BA, Sicks JD, Whisnant JP. Factors affecting survival and occurrence of stroke in patients with transient ischemic attacks. Mayo Clin. Proc. 69, 416–421 (1994).
  • Sacco RL. Risk factors for TIA and TIA as a risk factor for stroke. Neurology 62(8) (Suppl. 6), S7–S11 (2004).
  • Whisnant JP, Brown RD, Petty GW et al. Comparison of population-based models of risk factors for TIA and ischemic stroke. Neurology 53, 532–536 (1999).
  • Fuster V, Rydén LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 38, 1231–1266 (2001).
  • Donnan GA, Davis SM. Patent foramen ovale and recurrent stroke. Stroke 35, 803–806 (2004).
  • Johnston SC, Fayad PB, Gorelick PB et al. Prevalence and knowledge of transient ischemic attacks among US adults. Neurology 60, 1429–1434 (2003).
  • Kimura K, Minematsu K, Yasaka M et al. The duration of symptoms in transient ischemic attack. Neurology 52, 976 (1999).
  • Petty GW, Brown RD, Whisnant JP et al. Ischemic stroke subtypes: a population based study of incidence and risk factors. Stroke 30, 2513–2516 (1999).
  • Kapral KM, Silver FL. Preventative healthcare, 1999 update, 2: echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventative Healthcare. CMAJ 161, 989–996 (1999).
  • Peterson GE, Brickner ME, Reimold SC. Transesophageal echocardiography: clinical indications and applications. Circulation 107, 2398–2402 (2003).
  • Schaer BA, Zellweger MD, Cron TA et al. Value of routine holter monitoring for detection of paroxysmal atrial fibrillation in patients with cerebral ischemic events. Stroke 35, E68–E70 (2004).
  • Jerrard-Dunne P, Evans A, McGovern R et al. Ethnic differences in markers of thrombophilia. Stroke 34, 1821–1827 (2003).
  • Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31, 3067–3078 (2002).
  • Nederkoorn PJ, Willem PTM, Mali MD et al. Preoperative diagnosis of carotid artery stenosis, accuracy of noninvasive testing. Stroke 33, 2003–2008 (2002).
  • Bendszus M, Koltzenburg M, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet 354, 1594–1597 (1999).
  • Kirsch JD, Wagner LR, James EM et al. Carotid artery occlusion: positive predictive value of duplex sonography compared with arteriography. J. Vasc. Surg. 19, 642–649 (1994).
  • Koelemay M, Nederkoorn PJ, Reitsma JB, Majoie CB. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 35, 2306–2312 (2004).
  • Nederkoorn PJ, van der Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis, a systematic review. Stroke 34, 1324–1332 (2003).
  • Fazekas F, Fazekas G, Schmidt R et al. Magnetic resonance imaging correlates of transient cerebral ischemic attacks. Stroke 27, 607–611 (1996).
  • Schaefer PW. Applications of DWI in clinical neurology. J. Neurol. Sci. 186(Suppl. 1), S25–S35 (2001).
  • Inatomi Y, Kimura K, Yonehara T et al. DWI abnormalities and clinical characteristics in TIA patients. Neurology 62, 376–380 (2004).
  • Purroy F, Montaner J, Rovira A et al. Higher risk of further vascular events among transient attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 35, 2313–2319 (2004).
  • Crisostomo RA, Garcia MM, Tong DC. Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack, correlation with clinical characteristics. Stroke 34, 932–937 (2003).
  • Hjort N, Butcher K, Davis SM et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 36, 388–397 (2005).
  • Intercollegiate WorkingParty for Stroke. National Clinical Guidelines for Stroke. Royal College of Physicians of London, London, UK (2000).
  • Albers GW, Hart RG, Lutsep HL et al. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, stroke Council, American Heart Association. Stroke 30, 2502–2511 (1999).
  • Antithrombotic Trialists’Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients. BMJ 323, 71–86 (2002).
  • The Dutch TIA TrialStudy Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N. Engl. J. Med. 325, 1261–1266 (1991).
  • European Carotid SurgeryTrialists’ Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 337, 1235–1243 (1991).
  • The task force on theuse of antiplatelet agents in patients with atherosclerotic cardiovascular diseaseof the European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. Eur. Heart J. 25, 166–181 (2004).
  • CAPRIE Steering Committee. A randomised, blinded trial of Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE). Lancet 348, 1329–39 (1996).
  • Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364, 331–337 (2004).
  • Diener HC, Cunha L, Forbes C et al. European Stroke Prevention Study-2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 143, 1–13 (1996).
  • Tran H, Anand SS. Oral antiplatelet therapy in cerbrovascular disease, coronary artery disease and peripheral arterial disease. JAMA 292, 1867–1874 (2004).
  • Algra A, de Schryver EL, van Gijn J et al. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin. Cochrane Database Syst. Rev. (4) CD001342 (2001).
  • Gubitz G, Counsell C, Sandercock P et al. Anticoagulants for acute ischemic stroke. Cochrane Database Syst. Rev. (2) CD000024 (2000).
  • Johnston SC. Transient ischemic attack. N. Engl. J. Med. 347, 1687–1692 (2002).
  • Iannuzzi A, Wilcosky T, Mercuri M et al. Ultrasonographic correlates of carotid atherosclerosis in transient ischemic attack and stroke. Stroke. 32, 1953–1959 (1995).
  • Streifler JY, Eliasziw M, Benavente OR et al. The risk of stroke in patients with first-ever retinal vs. hemispheric transient ischemic attacks and high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial. Arch. Neurol. 52, 246–249 (1995).
  • Moore WS, Barnett HJ, Beebe HG et al. Guidelines for carotid endarterectomy: a multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Stroke 26, 188–201 (1995).
  • Biller J, Feinberg WM, Castaldo JE et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 29, 554–562 (1998).
  • Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363, 915–924 (2004).
  • Bond R, Rerkasem K, Rothwell PM. Systematic review of the risks of carotid endarterctomy in relation to the clinical indication for and timing of surgery. Stroke 34, 2290–2303 (2003).
  • O’Neill L, Lanska DJ, Hartz A. Surgeon characteristics associated with mortality and morbidity following carotid endartectomy. Neurology 55, 773–781 (2000).
  • Gasparis AP, Ricotta L, Cuadra SA et al. High-risk carotid endarterectomy: fact or fiction. J. Vasc. Surg. 37, 40–46 (2003).
  • CAVATAS collaborators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357, 1729–1737 (2001).
  • Yadav JS. Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve. Clin. J. Med. 71(Suppl. 1), S45–S46 (2004).
  • Brott TG, Brown RD, Meyer FB, Miller DA, Cloft HJ, Sullivan TM. Carotid revascularisation for prevention of stroke: carotid endarterectomy and carotid artery stenting. Mayo Clin. Proc. 79(9), 1197–1208 (2004).
  • Blaser T, Hoffman K, Buerger T et al. Risk of stroke, transient ischemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. Stroke 33, 1057–1062 (2002).

Websites

  • National Institute for Clinical Excellence. Final Appraisal Determination: Clopidogrel and modified release dipyridamole in the prevention of occlusive vascular events. www.nice.org.uk/page.aspx?o=228262 (Accessed June 2005)
  • Department of Health, London, UK. National service framework for older people. www.dh.gov.uk (Accessed June 2005)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.